UmanDiagnostics is an innovative in vitro diagnostics company specializing in the detection of diseases of the brain. The company manufactures and supplies the NF-Light™ antibodies and ELISA kits, which are widely recognized by researchers and biopharmaceutical and diagnostics companies world-wide as the premier solution for the detection of Neurofilament light (Nf-L), to advance the development of therapeutics and diagnostics for neurodegenerative conditions. The company was established in 2006, became a subdivision of Quanterix in 2019, and is located in Umea, Sweden.